Is It Too Late to Buy Vertex Pharmaceuticals Stock? The Motley Fool Shares of the growing biotech company have doubled in three years. Business Nasdaq 100 Pharmaceuticals Vertex (VRTX) 1 month
FedEx cost cuts are delivering results, and potential freight spinoff is ‘tantalizing’: analysts MarketWatch 1 hour
I tried and ranked 5 Burger King cheeseburgers from worst to best, and the winner was the most classic Business Insider 1 hour
Robinhood Stock Surges On Upgrade; Analyst Estimates ‘Much Too Low’ Investor's Business Daily 2 hours
‘Do You Like the Taste of Making Money?’ Investors Weigh In on Crazy New Food Biz Pitches. Entrepreneur 3 hours
Zumiez Business Is Improving And Reasonably Priced, But Still A Conservative Hold Seeking Alpha 3 hours
Investing $1,000 Into Each of These Top ETFs Would Incur a Mere $12 Annual Fee, and They Have All Beaten the S&P 500 and Nasdaq Composite So Far in 2024 The Motley Fool 4 hours
Halfway Into 2024, This Cathie Wood Stock Is Down 9%. But Does Recent News Suggest It Could Be Headed for the Moon? The Motley Fool 5 hours
2 Undervalued Growth Stocks to Buy Before They Soar 71% and 1,000%, According to Certain Wall Street Analysts The Motley Fool 5 hours
U.S. chip curbs in Middle East just ‘business as usual,’ Ooredoo CEO says after Nvidia deal CNBC 6 hours
Conduent Incorporated (CNDT): Why Are Analysts Optimistic About This AI Stock’s Future? Insider Monkey 12 hours
Stock market today: Nvidia rebound fuels Nasdaq rally as Dow falls 300 points | June 25, 2024 YouTube 16 hours